Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension (2008)
- Autores:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.clinbiochem.2008.04.015
- Assuntos: HIPERTENSÃO NA GRAVIDEZ; PRÉ-ECLÂMPSIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Clinical Biochemistry
- ISSN: 0009-9120
- Volume/Número/Paginação/Ano: v. 41, n. 10-11, p. 875-880, 2008
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PALEI, Ana C. T. et al. Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clinical Biochemistry, v. 41, n. 10-11, p. 875-880, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.clinbiochem.2008.04.015. Acesso em: 19 set. 2024. -
APA
Palei, A. C. T., Sandrim, V. C., Cavalli, R. C., & Tanus-Santos, J. E. (2008). Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clinical Biochemistry, 41( 10-11), 875-880. doi:10.1016/j.clinbiochem.2008.04.015 -
NLM
Palei ACT, Sandrim VC, Cavalli RC, Tanus-Santos JE. Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension [Internet]. Clinical Biochemistry. 2008 ; 41( 10-11): 875-880.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.clinbiochem.2008.04.015 -
Vancouver
Palei ACT, Sandrim VC, Cavalli RC, Tanus-Santos JE. Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension [Internet]. Clinical Biochemistry. 2008 ; 41( 10-11): 875-880.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.clinbiochem.2008.04.015 - Atorvastatina reduz a hipertensão arterial pulmonar causada por embolia pulmonar aguda (EPA) em ratos
- Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome
- Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble Fms-like tyrosine kinase-1 and soluble endogline in preeclampsia
- Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients
- Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms
- Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism
- Matrix metalloproteinase-9 genetic variation affect MMP-9 levels in obese children
- Sodium nitrite does not inhibit circulating angiotensin converting enzyme activity
- Matrix metalloproteinases as drug targets in preeclampsia
- Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension
Informações sobre o DOI: 10.1016/j.clinbiochem.2008.04.015 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
